Ben Adams on Muck Rack

Ben Adams

Verified
Chichester
As seen in: Fierce Biotech, Fierce Pharma, Questex Media Group, The Telegraph, The BMJ, Europa Press, The Lancet, EIN News, MERRY JANE, Wealth of Geeks, Fierce Healthcare, La Crosse Tribune, The Top Line and
Senior editor of Fierce Pharma Marketing
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ben

Contact Ben, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Guardant Health nabs FDA test approval to find patients for Boehringer’s new cancer drug

|
By Ben Adams 
| Fierce Biotech
Boehringer Ingelheim’s Hernexeos has nabbed a companion diagnostic from Guardant Health after the FDA cleared its liquid biopsy test, Guardant360 CDx. Hernexeos was approved last August for previously treated non-small cell lung cancer (NSCLC) patients who have relatively rare HER2 activating mutations in the tyrosine kinase domain. The mutated cancer type occurs in around 2% to 4% of NSCLC cases and affects around 40,000 patients globally.
Open in Who Shared Issue with article?

Lilly, Biogen, Eisai and Genentech sponsor new ‘Let’s Talk Alzheimer’s’ podcast

|
By Ben Adams 
| The Top Line
Audio is becoming an increasingly important area of focus in pharma marketing, and now four big drugmakers have become sponsors for a new podcast focusing in on Alzheimer’s disease (AD). Eli Lilly, Biogen, Eisai and Genentech, all which work on and market AD treatments and diagnostics, have signed up to BrightFocus Foundation’s “Let’s Talk Alzheimer’s,” according to a June 11 release.
Open in Who Shared Issue with article?

Olixir NY teams with Crohn's & Colitis Foundation for ‘Spill Your Guts’ campaign

|
By Ben Adams 
| The Top Line
The Crohn's & Colitis Foundation has tapped agency Olixir NY for its new inflammatory bowel disease (IBD) public service announcement. Called “Spill Your Guts,” the latest iteration of this campaign shares stories from real patients about their experiences living with Crohn’s disease and ulcerative colitis. Many people, when thinking about these disorders, see the main issues as having to use the toilet a lot, but for IBD patients, the toll can go far beyond symptoms, according to the foundation.
Open in Who Shared Issue with article?
See all 2,498 licensed articles (2,676 Total)

Actions

Share this page

Get in touch with Ben

Contact Ben, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified